Disrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activation

Journal: Science Translational Medicine

Published: 2020-07-22

DOI: 10.1126/scitranslmed.aar8430

Affiliations: 8

Authors: 20

Go to article
Institutions Share
Australian Centre for Blood Diseases (ACBD), Monash University, Australia 0.33
Medicinal Chemistry, Monash University, Australia 0.25
Biology and Pharmacology of Blood Platelets, France 0.15
Institute of Cardiovascular and Metabolic Diseases (I2MC), France 0.10
Faculty of Medicine, UI, Indonesia 0.05
Centre for Inflammatory Diseases (CID), Monash University, Australia 0.05
Monash Medical Centre (MMC), Australia 0.05
School of Engineering, RMIT University, Australia 0.03

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER